User profiles for Maria Mazzitelli
 | Maria MazzitelliVerified email at aopd.veneto.it Cited by 1992 |
[HTML][HTML] Hepatic ischemia reperfusion injury: A systematic review of literature and the role of current drugs and biomarkers
…, A Zullo, G Gallelli, S Serafini, M Maria… - International journal of …, 2016 - Elsevier
Hepatic ischemia reperfusion injury (IRI) is not only a pathophysiological process involving
the liver, but also a complex systemic process affecting multiple tissues and organs. Hepatic …
the liver, but also a complex systemic process affecting multiple tissues and organs. Hepatic …
[HTML][HTML] Heparin in COVID-19 patients is associated with reduced in-hospital mortality: the multicenter Italian CORIST study
…, L Marra, F Mastroianni, M Mazzitelli… - Thrombosis and …, 2021 - thieme-connect.com
Introduction A hypercoagulable condition was described in patients with coronavirus disease
2019 (COVID-19) and proposed as a possible pathogenic mechanism contributing to …
2019 (COVID-19) and proposed as a possible pathogenic mechanism contributing to …
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study
Background Hydroxychloroquine (HCQ) was proposed as potential treatment for COVID-19.
Objective We set-up a multicenter Italian collaboration to investigate the relationship …
Objective We set-up a multicenter Italian collaboration to investigate the relationship …
[HTML][HTML] Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility
Since December 2019, coronavirus disease 2019 (COVID-19) pandemic has spread from
China all over the world and many COVID-19 outbreaks have been reported in long-term care …
China all over the world and many COVID-19 outbreaks have been reported in long-term care …
Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae …
…, R Lionello, F Serapide, M Mazzitelli… - Journal of …, 2019 - academic.oup.com
Sir, Cefiderocol is a new siderophore cephalosporin, with potent activity against MDR Gram-negative
bacilli. It is particularly active against XDR Acinetobacter baumannii (Ab) infections, …
bacilli. It is particularly active against XDR Acinetobacter baumannii (Ab) infections, …
[HTML][HTML] Use of subcutaneous tocilizumab in patients with COVID‐19 pneumonia
M Mazzitelli, E Arrighi, F Serapide… - Journal of medical …, 2021 - ncbi.nlm.nih.gov
To the Editor, Di Giambenedetto et al. 1 described their experience with intravenous tocilizumab
(TCZ) in treating severe coronavirus disease 2019 (COVID‐19). This adds to several …
(TCZ) in treating severe coronavirus disease 2019 (COVID‐19). This adds to several …
[HTML][HTML] Population pharmacokinetic and pharmacodynamic analysis of dalbavancin for long-term treatment of subacute and/or chronic infectious diseases: the major …
…, E Zamparini, M Meschiari, PD Siega, M Mazzitelli… - Antibiotics, 2022 - mdpi.com
A population pharmacokinetic analysis of dalbavancin was conducted in patients with different
infection sites. Non-linear mixed effect modeling was used for pharmacokinetic analysis …
infection sites. Non-linear mixed effect modeling was used for pharmacokinetic analysis …
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study
…, EM Trecarichi, M Mazzitelli… - Therapeutic …, 2020 - journals.sagepub.com
The worldwide spread of coronavirus disease 2019 (COVID-19), caused by the new severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a pandemic by the …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a pandemic by the …
Risk of hospitalization and sequelae in patients with COVID‐19 treated with 3‐day early remdesivir vs. controls in the vaccine and Omicron era: A real‐life cohort study
M Mazzitelli, M Trunfio, L Sasset… - Journal of Medical …, 2023 - Wiley Online Library
Recently, a benefit from administration of a 3‐day course of early remdesivir (ER) in the
outpatients' setting was reported. However, real‐life data on its use is scarce. Therefore, we …
outpatients' setting was reported. However, real‐life data on its use is scarce. Therefore, we …
[HTML][HTML] Cefiderocol-Based versus Colistin-Based Regimens for Severe Carbapenem-Resistant Acinetobacter baumannii Infections: A Propensity Score-Weighted …
M Mazzitelli, D Gregori, L Sasset, M Trevenzoli… - Microorganisms, 2023 - mdpi.com
Background. A large increase in multi-drug-resistant Acinetobacter baumannii, especially
carbapenem-resistant strains, occurred during the first two years of the COVID-19 pandemic, …
carbapenem-resistant strains, occurred during the first two years of the COVID-19 pandemic, …